Comparing language used during anesthesia induction in children
A Prospective Randomized Study Comparing Positive Language vs Common Language During Inhalational Induction
This study tests whether using positive language instead of standard language during anesthesia can help reduce anxiety and negative behaviors in children aged 5 to 10 years.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 128 (estimated) |
| Ages | 5 Years to 10 Years |
| Sex | All |
| Sponsor | Boston Children's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT06324955 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effects of standard versus positive language used by clinicians during inhalational induction of anesthesia on anxiety and negative behaviors in children aged 5 to 10 years. It is a prospective randomized parallel group trial where participants will be assigned to either the common language group or the positive language group. The goal is to determine if the type of language used can influence the child's experience during anesthesia induction.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy children aged 5 to 10 years who are undergoing non-emergent procedures requiring inhalational induction.
Not a fit: Patients who may not benefit from this study include those with behavioral difficulties, hearing impairments, or those who do not speak English.
Why it matters
Potential benefit: If successful, this study could lead to improved experiences and reduced anxiety for children undergoing anesthesia.
How similar studies have performed: Other studies have explored the impact of communication styles in medical settings, suggesting that positive language may improve patient experiences, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA 1 and 2 (Healthy Patients) * Non-emergent cases * 5-10 year olds * Patients receiving inhalational induction Exclusion Criteria: * Non-English speaking * History of prior inhalational inductions * Hearing difficulty * Behavioral difficulty (Autism, Oppositional Defiant Disorder) * Patients receiving premedication other than midazolam
Where this trial is running
Boston, Massachusetts
- Boston Children's Hospital — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: John Fiadjoe, MD — Boston Children's Hospital
- Study coordinator: John Fiadjoe, MD
- Email: john.fiadjoe@childrens.harvard.edu
- Phone: 617-355-7737
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.